Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: A randomised study

British Journal of Haematology

Volumn 130, Issue 1, 2005, Pages 96-98

  Ljungman, Per ^a   Nahi, Hareth ^a   Linde, Annika ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Institute for Communicable Infectious Disease Control   (Sweden)

Author keywords

Haematological malignancies; Influenza; Vaccination

Indexed keywords

ALEMTUZUMAB; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; RITUXIMAB;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IMMUNOTHERAPY; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STATISTICAL ANALYSIS; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; DRUG ADMINISTRATION SCHEDULE; HEMATOLOGIC NEOPLASMS; HUMANS; INFLUENZA VACCINES; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT FAILURE;

EID: 22144455743     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05582.x     Document Type: Article

References (8)

1. Center for Disease Control and Prevention (1992) Prevention and control of influenza. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report, 41 (RR-9), 1-17.
2. Biting, L.S., Whimbey, E., Lo, W., Couch, R., Andreeff, M. & Bodey, G.P. (1995) Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Supportive Care in Cancer, 3, 198-202.
3. Gribabis, D.A., Panayiotidis, P., Boussiotis, V.A., Hannoun, C. & Pangalis, G.A. (1994) Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematologica, 91, 115-118.
4. Ljungman, P., Andersson, J., Aschan, J., Barkholt, L., Ehrnst, A., Johansson, M. & Weiland, O. (1993) Influenza A in immunocompromised patients. Clinical Infectious Diseases, 17, 244-247.
5. Lo, W., Whimbey, E., Elting, L., Couch, R., Cabanillas, F. & Bodey, G. (1993) Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. European Journal of Clinical Microbiology and Infectious Diseases, 12, 778-782.
6. Machado, CM., Boas, L.S., Mendes, A.V., da Rocha, I.E., Sturaro, D., Dulley, F.L. & Pannuti, C.S. (2004) Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplantation, 34, 111-114.
7. Rapezzi, D., Sticchi, L., Racchi, O., Mangerini, R., Ferraris, A.M. & Gaetani, G. F. (2003) Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. European Journal of Haematology, 70, 225-230.
8. Robertson, J.D., Nagesh, K., Jowitt, S.N., Dougal, M., Anderson, H., Mutton, K., Zambon, M. & Scarffe, J.H. (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. British Journal of Cancer, 82, 1261-1265.